Deepinder Goyal's Temple claims discovery of biomarker that calculates cost of being alive; here’s what it means
Published on: June 19, 2026, 11:18 a.m. | Source: The Economic Times
Deepinder Goyal's startup Temple has unveiled 'Entropy,' a new biomarker measured on the temple region to quantify the real-time cost of being alive. This metric, displayed as a live score, aims to help users understand and optimize their body's energy expenditure during rest and exertion.
